Technology
Health
Medical

Zynerba Pharmaceuticals

33,253

$3.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-6.00%) Today
-$0.01 (-0.31%) As of 8:28 AM EDT after-hours

Why Robinhood?

You can buy or sell ZYNE and other stocks, options, ETFs, and crypto commission-free!

About ZYNE

Zynerba Pharmaceuticals, Inc. engages in the provision of pharmaceutically-produced transdermal cannabinoid therapies. It focuses on research and development of rare and near-rare neuropsychiatric conditions. Read More It offers Zygel product which formulated as a permeation-enhanced gel for transdermal delivery. The company was founded by Audra L. Stinchcomb on January 31, 2007 and is headquartered in Devon, PA.

CEO
Armando Anido
Employees
28
Headquarters
Devon, Pennsylvania
Founded
2007
Market Cap
82.09M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.86M
High Today
$3.50
Low Today
$3.27
Open Price
$3.50
Volume
2.18M
52 Week High
$15.58
52 Week Low
$2.55

Collections

Technology
Health
Medical
Pharmaceutical
2015 IPO
US
North America

ZYNE News

BenzingaJun 30

Synthetic Cannabinoid Drug Maker Zynerba Plummets 50%

Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) shares retreated to their lowest level since early April following a clinical readout from the company. What Happene
0

ZYNE Earnings

-$0.65
-$0.43
-$0.22
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 6, Pre-Market

You May Also Like

IXP
EKAR
HGSH
METXW
DVYA
IBTJ
DX-B
CNR
SPHD
BIMI
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ZYNE

Market Price$3.28
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ZYNE stock and options commission-free.
LearnBlogCareersHelpLog InSign Up